![Jeanne Ohrnberger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jeanne Ohrnberger worked as a Laboratory Director at Armune BioScience, Inc. and CLIA, Inc. She earned a doctorate degree from Wayne State University (Michigan) in 1994.
Ehemalige bekannte Positionen von Jeanne Ohrnberger
Unternehmen | Position | Ende |
---|---|---|
Armune BioScience, Inc.
![]() Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Corporate Officer/Principal | 01.12.2017 |
CLIA, Inc. | Corporate Officer/Principal | - |
Ausbildung von Jeanne Ohrnberger
Wayne State University (Michigan) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Armune BioScience, Inc.
![]() Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Health Services |
CLIA, Inc. |